Markets

Insider Trading

Hedge Funds

Retirement

Opinion

11 Cheap Pot Stocks to Buy

In this article, we discuss the 11 cheap pot stocks to buy. If you want to skip our detailed analysis of these stocks, go directly to 5 Cheap Pot Stocks to Buy.

As with any nascent industry, the pot industry around the world has been facing a plethora of challenges and opportunities over the past few months. In the United States and Europe, the focus of investors remains on key policy reform around the legalization of marijuana. There are even countries in South America and Asia that are considering cannabis mainstreaming. In Canada, where the pot industry is flourishing, investors are now looking towards mergers and acquisition activity, as well as a rightsizing of the market, to place their bets. 

According to a report by Fortune Business Insights, the global cannabis market is expected to grow at a compound annual rate of more than 34% in the next five years, expanding from $57 billion in size to more than $444 billion. Rami El-Cheikh, a top partner at strategy consulting firm EY Pantheon, recently told finance news platform INN that access to capital markets remains a key concern for many cannabis firms heading into 2024. Per Cheikh, the capital markets in the United States will play an important role in cannabis growth. 

“I think there’s going to be more acceleration of bankruptcies and restructurings in 2024. I think the balance sheets are very stretched. So that’s going to be very problematic, and (even though) a lot of the cannabis companies have been very active with their cost-reduction programs, I don’t know to what extent they can further reduce costs and further streamline their operations. They’ve been at it for about a year or two years now. So without improved capital markets (or) competitors exiting the market, it’s going to continue to be a challenging, challenging industry.”

Even though the challenges remain, companies like Tilray Brands, Inc. (NASDAQ:TLRY), WM Technology, Inc. (NASDAQ:MAPS), and Cronos Group Inc. (NASDAQ:CRON) are writing their own growth stories. Mike Gorenstein, the executive chairman of Cronos Group Inc. (NASDAQ:CRON), said during a recent earnings call that even though his company was focused on growing in established markets, it had already begun exploring ways to increase presence in emerging cannabis markets like Germany and Australia. 

“We continue to have an industry-leading balance sheet with a cash and short-term investment balance of approximately $840 million. The strength of our balance sheet is supported by improved gross margin, lower operating expenses, robust interest income, and improved working capital management. We intend to build on this momentum for the remainder of the year and into 2024 as we realize P&L efficiencies and additional interest income from our cash and short-term investments. In September, we sent our first order of cannabis to our German distribution partner, Cansativa, and we are very excited to bring the Peace Naturals brand back to the German market.

Cansativa is one of the leading distributors of medical cannabis in Germany and has a network of approximately 2,000 high-volume cannabis-focused pharmacies that currently supply around 300,000 patients. Re-entering the German market, which has about 83 million people, is a significant milestone for us. We are working closely with the Cansativa sales team, who are excited about selling this brand in the market. Traction in the early innings of our launch is strong and Cansativa has already received significant orders of Peace Naturals.

Our goal is to continue to expand our reach and brand awareness in Germany with the help of Cansativa to establish our Peace Naturals brand as a top medical brand, similar to the brand’s reputation in other international markets. Re-establishing Cronos and our Peace Naturals brand in the German market will position us to capitalize on this growing opportunity with additional upside potential from future legislative changes, including in the event the German government reschedules cannabis and no longer labels cannabis as a narcotic. Turning to Australia, we are in the process of filing our first order to Vitura with the first shipment to Australia planned to go out later this month. As a reminder, Cronos owns approximately 10% of the common shares of Vitura.”

Our Methodology

The companies that operate in the pot sector and were priced under $3 per share, as of December 26, were selected for the list and ranked according to hedge fund sentiment. Data from around 900 elite hedge funds tracked by Insider Monkey in the third quarter of 2023 was used to identify the number of hedge funds that hold stakes in each firm. Hedge funds’ top 10 consensus stock picks outperformed the S&P 500 Index by more than 140 percentage points over the last 10 years (see the details here). That’s why we pay very close attention to this often-ignored indicator.

A doctor in a lab coat discussing the potential complexities of treating cancer with cannabinoid medicines.

Cheap Pot Stocks to Buy

11. SNDL Inc. (NASDAQ:SNDL)

Number of Hedge Fund Holders: 3    

Real Time Share Price as of December 26: $1.54  

SNDL Inc. (NASDAQ:SNDL) is a Canada-based firm that markets cannabis products. On November 13, SNDL Inc. (NASDAQ:SNDL) posted earnings for the third quarter of 2023, reporting a revenue of C$237 million, up more than 3% compared to the revenue over the same period last year. 

At the end of the third quarter of 2023, 3 hedge funds in the database of Insider Monkey held stakes worth $1.3 million in SNDL Inc. (NASDAQ:SNDL), compared to 2 the preceding quarter worth $1.2 million.

Just like Tilray Brands, Inc. (NASDAQ:TLRY), WM Technology, Inc. (NASDAQ:MAPS), and Cronos Group Inc. (NASDAQ:CRON), SNDL Inc. (NASDAQ:SNDL) is one of the cheap pot stocks to buy. 

10. Village Farms International, Inc. (NASDAQ:VFF)

Number of Hedge Fund Holders: 4 

Real Time Share Price as of December 26: $0.76

Village Farms International, Inc. (NASDAQ:VFF) markets agricultural products. On November 9, investment advisory Craig-Hallum upgraded Village Farms International, Inc. (NASDAQ:VFF) stock to Buy from Hold with a price target of $1. 

At the end of the third quarter of 2023, 4 hedge funds in the database of Insider Monkey held stakes worth $243,000 in Village Farms International, Inc. (NASDAQ:VFF), compared to 5 in the preceding quarter worth $250,000. 

Among the hedge funds being tracked by Insider Monkey, New York-based investment firm Millennium Management is a leading shareholder in Village Farms International, Inc. (NASDAQ:VFF) with 209,995 shares worth more than $167,000. 

9. Clever Leaves Holdings Inc. (NASDAQ:CLVR)

Number of Hedge Fund Holders: 4  

Real Time Share Price as of December 26: $2.20

Clever Leaves Holdings Inc. (NASDAQ:CLVR) operates in the botanical cannabinoid and nutraceutical industries. On November 9, Clever Leaves Holdings Inc. (NASDAQ:CLVR) posted earnings for the third quarter of 2023, reporting a revenue of $3.8 million, up more than 15% compared to the revenue over the same period last year. 

At the end of the third quarter of 2023, 4 hedge funds in the database of Insider Monkey held stakes worth $10,000 in  Clever Leaves Holdings Inc. (NASDAQ:CLVR), compared to 6 in the previous quarter worth $351,000.

Among the hedge funds being tracked by Insider Monkey, New York-based investment firm Renaissance Technologies is a leading shareholder in Clever Leaves Holdings Inc. (NASDAQ:CLVR) with 28,489 shares worth more than $98,000. 

8. Organigram Holdings Inc. (NASDAQ:OGI)

Number of Hedge Fund Holders: 4   

Real Time Share Price as of December 26: $1.26

Organigram Holdings Inc. (NASDAQ:OGI) engages in the production and sale of cannabis and cannabis-derived products in Canada. On December 19, Organigram Holdings Inc. (NASDAQ:OGI) posted earnings for the fourth fiscal quarter, reporting a revenue of C$46 million, up over 1% compared to the revenue over the same period last year. 

At the end of the third quarter of 2023, 4 hedge funds in the database of Insider Monkey held stakes worth $336,000 in Organigram Holdings Inc. (NASDAQ:OGI), compared to 5 in the previous quarter worth $808,000.

Among the hedge funds being tracked by Insider Monkey, New York-based investment firm DE Shaw is a leading shareholder in Organigram Holdings Inc. (NASDAQ:OGI) with 162,425 shares worth more than $215,000. 

7. High Tide Inc. (NASDAQ:HITI)

Number of Hedge Fund Holders: 5   

Real Time Share Price as of December 26: $1.60

High Tide Inc. (NASDAQ:HITI) engages in the cannabis retail business in Canada, the United States, and internationally. In late November, High Tide Inc. (NASDAQ:HITI) announced that it had purchased certain assets of Canadian Cannabis Media related to the store located on Davie Street in Vancouver for $1.3 million. 

Among the hedge funds being tracked by Insider Monkey, New York-based investment firm Millennium Management is a leading shareholder in High Tide Inc. (NASDAQ:HITI) with 68,831 shares worth more than $127,000. 

At the end of the third quarter of 2023, 5 hedge funds in the database of Insider Monkey held stakes worth $380,000 in High Tide Inc. (NASDAQ:HITI), compared to 4 in the previous quarter worth $190,000.

6. Aurora Cannabis Inc. (NASDAQ:ACB)

Number of Hedge Fund Holders: 9

Real Time Share Price as of December 26: $0.48

Aurora Cannabis Inc. (NASDAQ:ACB) produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. In early November, Aurora Cannabis Inc. (NASDAQ:ACB) posted earnings for the second fiscal quarter, reporting a revenue of C$63 million, up over 30% compared to the revenue over the same period last year. 

At the end of the third quarter of 2023, 9 hedge funds in the database of Insider Monkey held stakes worth $47.7 million in Aurora Cannabis Inc. (NASDAQ:ACB), compared to 10 in the previous quarter worth $45.7 million.

Among the hedge funds being tracked by Insider Monkey, New York-based investment firm Millennium Management is a leading shareholder in Aurora Cannabis Inc. (NASDAQ:ACB) with 1.6 million shares worth more than $945,000. 

In addition to Tilray Brands, Inc. (NASDAQ:TLRY), WM Technology, Inc. (NASDAQ:MAPS), and Cronos Group Inc. (NASDAQ:CRON), Aurora Cannabis Inc. (NASDAQ:ACB) is one of the cheap pot stocks to buy. 

Click to continue reading and see 5 Cheap Pot Stocks to Buy.

Suggested Articles:

Disclose. None. 11 Cheap Pot Stocks to Buy is originally published on Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…